XORTX Therapeutics Inc. (XRTX) stock
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06+0.02 (+1.92%)
Close on Nov 17, 2026Market cap $116.17KP/E –Yield –
XORTX Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
No operating income figures for XORTX Therapeutics
XORTX Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?